Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study

NCT ID: NCT07151235

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-18

Study Completion Date

2025-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine how breathing wildfire-related air pollution (WRAP) for one hour affects healthy adults. The main question the study will answer if the effect of WRAP exposure on p-tau, a blood marker of cognitive decline. The changes in p-tau concentrations after exposure to WRAP will be compared to the changes in p-tau after exposure to clean air.

Participants will:

* Have 2 study visits - one visit with exposure to clean air and one visit with exposure to simulated wildfire smoke
* Have blood drawn before and after each exposure
* Complete cognitive tests and memory tasks before and after each exposure

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Exposures will take place in a booth-like exposure chamber (1 x 0.7 x 1.8 m) with glass upper panels. One person will be exposed at a time.
* Simulated wildfire smoke will be generated by burning pine wood at a temperature that mimics smoldering combustion. The levels of smoke introduced into the exposure chamber are similar to those found during outdoor bonfires and wildfire events. The levels of particulate matter (PM) will be closely monitored during the exposure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Participants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will be exposed to two conditions (clean air and wildfire smoke) in random order.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors
outside laboratories processing blood samples

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exposure to simulated wildfire smoke, then exposure to clean air

At the first study visit the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 Particulate Matter). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM).

Group Type EXPERIMENTAL

Simulated wildfire smoke exposure

Intervention Type OTHER

1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)

Clean Air exposure

Intervention Type OTHER

1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)

Exposure to clean air, then exposure to simulated wildfire smoke

At the first study visit the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 PM).

Group Type EXPERIMENTAL

Simulated wildfire smoke exposure

Intervention Type OTHER

1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)

Clean Air exposure

Intervention Type OTHER

1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simulated wildfire smoke exposure

1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)

Intervention Type OTHER

Clean Air exposure

1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* Non smoker
* Weight at least 110 pounds
* Between ages 18 and 40 years old

Exclusion Criteria

* Claustrophobia or not comfortable in enclosed spaces.
* Colorblindness.
* Inability to hear verbal instructions.
* Cardiovascular disease which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure. This includes a history of stroke.
* Diabetes requiring the use of insulin.
* Pregnancy (A pregnancy test will be provided to you).
* Current asthma (an asthma attack within the past five years).
* History of childhood asthma.
* Medications which may affect cognition such as beta-blockers and CNS depressants.
* Respiratory symptoms in the previous 4 weeks (cough, wheezing, shortness of breath, etc.) which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure.
* Use of sedating cold/allergy medications in the previous week.
* Use of marijuana in the previous week.
* Consumption of alcohol in the previous 24 hours.
* Kidney or liver disease.
* Thyroid disease.
* High blood pressure.
* Cancer.
* Parkinson's disease.
* Pacemaker.
* Hay fever.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rutgers, The State University of New Jersey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose Guillermo CEDENO LAURENT, ScD

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose G Cedeno-Laurent, ScD

Role: PRINCIPAL_INVESTIGATOR

Rutgers, The State University of New Jersey: New Brunswick/Piscataway Campus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rutgers-EOHSI

Piscataway, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro2025001070

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Boston Puerto Rican Health Study
NCT03187704 COMPLETED NA